1,644 Shares of CME Group Inc. $CME Bought by NBT Bank N.A.

NBT Bank N.A. acquired a new stake in CME Group Inc. (NASDAQ:CME) in the 3rd quarter, Holdings Channel.com reports. The institutional investor acquired 1,644 shares of the financial services provider’s stock, valued at approximately $431,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. NBT Bank N A NY boosted its position in CME Group by 2.3% during the first quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock valued at $492,000 after purchasing an additional 38 shares during the last quarter. Resonant Capital Advisors LLC increased its position in shares of CME Group by 3.8% during the 1st quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock worth $317,000 after purchasing an additional 39 shares during the last quarter. Grove Bank & Trust increased its position in shares of CME Group by 0.8% during the 3rd quarter. Grove Bank & Trust now owns 5,038 shares of the financial services provider’s stock worth $1,320,000 after purchasing an additional 39 shares during the last quarter. Hartford Financial Management Inc. increased its position in shares of CME Group by 0.3% during the 3rd quarter. Hartford Financial Management Inc. now owns 13,093 shares of the financial services provider’s stock worth $3,430,000 after purchasing an additional 45 shares during the last quarter. Finally, Root Financial Partners LLC raised its stake in shares of CME Group by 13.2% during the 1st quarter. Root Financial Partners LLC now owns 394 shares of the financial services provider’s stock worth $116,000 after purchasing an additional 46 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Terrence A. Duffy sold 15,000 shares of CME Group stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $274.44, for a total transaction of $4,116,600.00. Following the completion of the sale, the chief executive officer owned 40,630 shares of the company’s stock, valued at approximately $11,150,497.20. The trade was a 26.96% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Elizabeth A. Cook sold 500 shares of the company’s stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $280.11, for a total transaction of $140,055.00. Following the completion of the transaction, the director owned 17,916 shares in the company, valued at approximately $5,018,450.76. This trade represents a 2.72% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 15,900 shares of company stock valued at $4,377,655. 0.30% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on CME shares. CLSA set a $367.00 price objective on CME Group in a research note on Thursday. UBS Group raised their target price on shares of CME Group from $270.00 to $310.00 and gave the company a “neutral” rating in a research note on Thursday. Barclays boosted their target price on shares of CME Group from $281.00 to $321.00 and gave the stock an “equal weight” rating in a report on Thursday. Wells Fargo & Company boosted their target price on shares of CME Group from $315.00 to $333.00 and gave the stock an “overweight” rating in a report on Thursday. Finally, TD Cowen upped their price target on shares of CME Group from $292.00 to $300.00 and gave the stock a “buy” rating in a research report on Monday, October 5th. Ten analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, CME Group currently has an average rating of “Hold” and an average target price of $313.29.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record quarterly results: CME reported third-quarter revenue of approximately $1.74 billion, up 10.6% year over year and above the $1.71 billion consensus estimate. EPS of $3.02 also exceeded expectations of $2.99, while average daily volume reached a record 29.4 million contracts. CME third-quarter revenue article
• Positive Sentiment: Crypto derivatives momentum: CME recorded approximately $469.5 billion in crypto derivatives volume during the third quarter, highlighting growing demand for regulated digital-asset products. The company has not separately disclosed crypto revenue, so the direct earnings contribution remains unclear. CME crypto derivatives volume article
• Positive Sentiment: More bullish analyst coverage: JPMorgan upgraded CME from “underweight” to “overweight” and set a $367 price target, citing improving volume and earnings prospects. Wells Fargo also raised its target to $333. JPMorgan CME rating
• Positive Sentiment: Expansion opportunities: CME plans to launch CME Securities Clearing on December 7, potentially broadening its clearing business. Management also highlighted strong participation and international volume growth. CME Securities Clearing article
• Neutral Sentiment: Valuation remains debated: UBS lifted its price target from $270 to $310 but retained a “neutral” rating, indicating that much of the improved outlook may already be reflected in the stock. UBS CME rating
• Negative Sentiment: Insider sale: Director Martin Gepsman sold 400 shares for approximately $121,000. The transaction reduced his holdings by 1.56%, but he still owns 25,244 shares, limiting the sale’s significance. CME director stock sale

CME Group Trading Down 0.1%

CME Group stock opened at $305.71 on Friday. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market capitalization of $109.93 billion, a P/E ratio of 25.08, a PEG ratio of 3.92 and a beta of 0.24. The stock has a 50-day simple moving average of $277.60 and a 200 day simple moving average of $270.74.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The business’s revenue was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.68 earnings per share. Analysts expect that CME Group Inc. will post 12.35 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th were paid a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date was Wednesday, September 9th. CME Group’s payout ratio is currently 42.66%.

CME Group Company Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.